Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a260c51a9c8f1baea32edfe5a3d3ee27 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
1990-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e68e2db0c37ca2eb21c68cdb885f9e |
publicationDate |
1991-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9108752-A1 |
titleOfInvention |
Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
abstract |
The present invention relates generally to a method for, and pharmaceutical compositions useful in, the treatment of thrombocytopenia in a mammal by the administration of an effective amount of leukaemia inhibitory factor (LIF) and/or its derivatives and optionally in combination with one or more other cytokines. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6506362-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723295-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251864-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6121238-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7091311-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067367-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7576056-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6465430-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8283313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227422-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5869451-A |
priorityDate |
1989-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |